Loss of Taste: What Could Be Causing It and What to Do Next

What "Loss of Taste" Actually Means Clinically

The term covers three distinct disorders that doctors and patients often conflate. Understanding which one applies changes the diagnostic path entirely.

Ageusia is complete taste loss. Hypogeusia is reduced taste sensitivity. Dysgeusia is distorted taste, where food tastes metallic, bitter, or rotten even when nothing is wrong with it. A fourth term, phantogeusia, describes taste sensations with no food present at all.

The Five Basic Taste Qualities

The tongue detects sweet, salty, sour, bitter, and umami through taste receptor cells clustered in taste buds on the papillae. Adults carry roughly 4,000 to 10,000 taste buds, each renewed every 10 to 14 days. Research published in Chemical Senses shows that cell turnover rate is one reason nutritional deficiencies, chemotherapy, and radiation damage taste so quickly.

Why "Taste" and "Flavor" Are Not the Same

Much of what people experience as taste is actually retronasal olfaction, the smell of food volatiles traveling up from the back of the throat. This matters clinically: patients who report "I can't taste anything" often have normal taste strip results but confirmed olfactory loss. A 2016 review in JAMA estimated that up to 80% of perceived flavor comes from smell. Separating gustatory from olfactory dysfunction is the first clinical step.

The Most Common Causes of Taste Loss

1. Viral Upper Respiratory Infections

Viruses are the single most frequent trigger. Influenza, rhinovirus, and SARS-CoV-2 all disrupt taste through inflammation of the taste buds, damage to supporting cells, and, in the case of SARS-CoV-2, direct infection of sustentacular cells in the olfactory epithelium.

A systematic review and meta-analysis of 24 studies (N=8,438) published in Annals of Internal Medicine found that 53.1% of COVID-19 patients reported chemosensory dysfunction, with taste loss specifically affecting 44.4%. Recovery data from a prospective Italian cohort (N=187) showed that 72% regained taste within 30 days and 84% within 60 days, though a minority develop persistent post-COVID chemosensory disorder lasting more than six months. [1]

2. Zinc Deficiency

Zinc is required for the synthesis of gustin, a zinc-dependent protein secreted by parotid glands that is thought to support taste bud development and maintenance. Serum zinc below 70 mcg/dL correlates with hypogeusia.

A randomized controlled trial published in the American Journal of Clinical Nutrition (N=106 elderly patients with hypogeusia) found that 25 mg elemental zinc daily for 16 weeks produced statistically significant improvement in taste acuity scores compared to placebo (P<0.01). Populations at risk include older adults, patients with Crohn's disease, those on long-term proton pump inhibitors, and people following strict vegan diets. [2]

3. Medications

More than 250 drugs list taste disturbance as a documented adverse effect. The mechanisms vary: some drugs bind to taste receptors directly, others alter saliva composition, and some cause zinc chelation.

High-frequency offenders include:

• ACE inhibitors (captopril, enalapril): metallic or salty dysgeusia in 0.5 to 1% of users
• Metformin: bitter aftertaste, reported in roughly 3% of users in the UKPDS cohort
• Clarithromycin: bitter metallic taste affecting up to 8% of patients in clinical trials
• Amlodipine and other calcium-channel blockers: dry-mouth-related hypogeusia
• Lithium carbonate: persistent metallic taste
• Chemotherapy agents (cisplatin, doxorubicin): direct taste bud cytotoxicity

A 2010 review in Drug Safety catalogued 362 medications associated with gustatory dysfunction across 11 drug classes. If taste loss began within weeks of starting a new prescription, a medication review is the highest-yield first step. [3]

4. Dry Mouth (Xerostomia)

Saliva is the solvent that carries tastant molecules to receptor cells. Without adequate salivary flow, taste sensitivity drops measurably. Xerostomia causes include Sjögren's syndrome, radiation to the head and neck, anticholinergic medications, and dehydration.

A study in Oral Diseases demonstrated that patients with Sjögren's syndrome had significantly lower taste recognition thresholds for all four classic tastants compared to age-matched controls. [4]

5. Nutritional Deficiencies Beyond Zinc

Vitamin B12 deficiency causes glossitis and atrophy of the tongue papillae, directly reducing taste bud density. Vitamin A deficiency impairs taste bud cell renewal because retinoids regulate epithelial differentiation. Iron deficiency anemia, independent of B12 status, also produces dysgeusia, typically a persistent metallic or "penny" taste. An NIH review of micronutrient-taste interactions provides a detailed mechanistic summary. [5]

6. Head and Neck Radiation

Radiation therapy to the head and neck damages both taste buds and salivary glands. Doses above 30 Gy to the tongue or floor of the mouth typically cause acute taste loss within the first two weeks of treatment. The American Cancer Society guidelines note that some patients recover taste function partially by 12 months post-radiation, but xerostomia-related dysfunction often persists indefinitely.

A prospective study of 60 patients receiving radiotherapy for nasopharyngeal carcinoma, published in Supportive Care in Cancer, found that peak taste loss occurred at week four and that zinc sulfate 45 mg three times daily during radiation significantly reduced severity compared to placebo. [6]

7. Neurological Causes

The taste pathway runs from chorda tympani nerve (cranial nerve VII) for the anterior two-thirds of the tongue, to the glossopharyngeal nerve (CN IX) for the posterior third, to the nucleus tractus solitarius in the brainstem, and then to the thalamus and gustatory cortex. A lesion anywhere along this route produces taste loss.

Bell's Palsy

Bell's palsy, an idiopathic peripheral facial nerve palsy, disrupts the chorda tympani branch of CN VII and causes unilateral taste loss in the anterior tongue. A Cochrane systematic review of corticosteroids for Bell's palsy (12 RCTs, N=1,987) concluded that prednisolone significantly improves complete recovery rates (NNT=6). Taste typically recovers alongside facial motor function. [7]

Stroke and Brain Lesions

Thalamic or insular cortex strokes can cause contralateral taste loss or dysgeusia. Multiple sclerosis plaques in the brainstem produce episodic gustatory symptoms. Acoustic neuroma can compress CN VIII near the chorda tympani and alter taste. Any new unilateral taste loss without a viral prodrome warrants MRI of the brain and posterior fossa.

Traumatic Brain Injury

Shear forces to olfactory filaments and, less commonly, to CN VII are the mechanism. A review in Archives of Physical Medicine and Rehabilitation found that 15.3% of patients with moderate-to-severe TBI reported chemosensory dysfunction at six-month follow-up. [8]

8. Endocrine and Systemic Conditions

Several systemic diseases alter taste through a combination of neuropathy, xerostomia, and nutritional depletion:

• Diabetes mellitus: peripheral gustatory neuropathy, reduced saliva, and zinc wasting through glycosuria all contribute. A study in Diabetes Care found that patients with type 2 diabetes had significantly higher taste detection thresholds for sweet and salty stimuli compared to controls.
• Chronic kidney disease: uremic compounds alter saliva composition and deposit on taste receptor membranes. Pre-dialysis patients often describe a persistent ammonia or bitter taste.
• Hypothyroidism: slowed taste bud cell renewal and reduced nerve conduction velocity both contribute. [9]
• Liver disease: hepatic encephalopathy produces zinc depletion and direct neurotoxicity.

9. Oral and Dental Causes

Periodontal disease, dental abscesses, oral candidiasis, and geographic tongue all alter the local chemical environment of taste buds. Denture adhesives containing zinc, used daily for years, have caused systemic zinc toxicity that paradoxically impairs rather than enhances taste. The FDA issued a safety communication on zinc-containing denture creams in 2009. [10]

10. Aging (Presbygeusia)

Taste bud number and sensitivity decline with age. After 50, the average number of taste buds begins to fall, and the replacement cycle slows from 10 to as many as 30 days per cell. By age 70, recognition thresholds for sweet, salty, and bitter increase by 30 to 40% compared to young adults, according to data reviewed by the National Institute on Deafness and Other Communication Disorders. Presbygeusia is a diagnosis of exclusion: reversible causes must be ruled out first. [11]

How Doctors Diagnose the Cause of Taste Loss

History and Medication Review

The clinical history answers 60 to 70% of taste-loss cases before a single test is ordered. Key questions include: timing relative to a viral illness or new prescription, laterality (bilateral suggests systemic or viral causes; unilateral suggests cranial nerve or central pathology), associated symptoms (facial droop, dysphagia, nasal congestion), and occupational exposures to organophosphates or heavy metals.

Taste Strip Testing

Taste strips, paper strips impregnated with defined concentrations of sweet, sour, salty, and bitter compounds, allow semi-quantitative testing of each taste quality across four intensity levels. The 16-strip Sniffin' Sticks taste protocol, validated in Laryngoscope, produces a score out of 16 with norms stratified by age and sex. A score below 9 defines hypogeusia. [12]

Blood Tests

A targeted panel typically includes:

• Serum zinc (reference range 70 to 120 mcg/dL)
• Complete blood count with MCV (B12/folate deficiency, iron deficiency)
• Serum B12 and ferritin
• Thyroid-stimulating hormone
• HbA1c and fasting glucose
• Comprehensive metabolic panel (renal and liver function)

Imaging

MRI of the brain with gadolinium is reserved for cases with unilateral taste loss, cranial nerve findings, or when stroke or mass lesion is suspected. CT of the temporal bones may be ordered if middle ear disease or cholesteatoma could explain CN VII involvement.

The HealthRX clinical team uses a three-tier triage framework for taste loss:

Tier 1 (Watchful waiting, 4 weeks): Bilateral taste loss with recent URI, no other neurological symptoms, no new medications, zinc and B12 within range.

Tier 2 (Targeted lab workup within 2 weeks): Taste loss persisting more than 4 weeks, recent chemotherapy or radiation, systemic disease known to affect taste, or medication started within 8 weeks of symptom onset.

Tier 3 (Urgent neurology or ENT referral within 72 hours): Unilateral taste loss, any facial weakness, dysphagia, hearing change, or taste loss following head trauma.

Treatment Options by Cause

Treating the Underlying Condition First

Most taste loss resolves once the root cause is addressed. Stopping a causative medication, treating periodontal disease, correcting hypothyroidism with levothyroxine, or completing dialysis for uremia each restore taste in parallel with the systemic improvement. There is no approved pharmacological treatment for taste loss as a primary endpoint.

Zinc Supplementation

For confirmed zinc deficiency, 25 to 45 mg of elemental zinc daily (commonly as zinc gluconate or zinc sulfate) is the standard approach. The trial referenced above showed meaningful improvement at 16 weeks. Taking zinc with food reduces nausea but may lower absorption by up to 40%, so timing recommendations vary by patient tolerance. Avoid doses above 40 mg/day long-term without monitoring, as excess zinc suppresses copper absorption. [2]

Gustatory Training

Analogous to olfactory training, gustatory training involves deliberate, concentrated exposure to defined tastes (sour, sweet, salty, bitter) for 10 to 20 seconds twice daily. A small RCT published in Otolaryngology - Head and Neck Surgery (N=60 post-COVID patients) found that gustatory training plus olfactory training produced significantly greater chemosensory recovery at 12 weeks compared to olfactory training alone (P<0.04). [13]

Salivary Substitutes and Stimulants

For xerostomia-driven taste loss, pilocarpine 5 mg three times daily (a muscarinic agonist) may increase salivary flow and partially restore taste function. Artificial saliva sprays provide short-term symptomatic relief. The FDA-approved pilocarpine prescribing information lists dry-mouth indications in radiation-treated patients specifically. [14]

Corticosteroids for Inflammatory Causes

Bell's palsy-related taste loss responds to prednisolone 60 mg/day for five days tapered over ten days, started within 72 hours of onset. Post-viral inflammatory hypogeusia without Bell's palsy does not have strong evidence for steroid benefit; the risk-benefit ratio rarely favors empirical steroids. [7]

When Taste Loss Signals Something Serious

Most taste loss is benign and self-limiting. Certain features, however, point toward a condition that needs prompt evaluation.

The American Academy of Neurology recommends urgent assessment for taste loss accompanied by any of the following:

• Unilateral facial weakness or numbness
• New difficulty swallowing or speaking
• Sudden hearing loss on the same side
• Onset after head trauma
• Accompanying vision changes

A BMJ clinical review of chemosensory disorders noted that taste loss as an isolated cranial nerve sign, particularly when progressive rather than static, warrants gadolinium-enhanced MRI to exclude skull base lesions. [15]

"Chemosensory dysfunction is frequently undertreated because clinicians and patients both assume it will resolve spontaneously," according to the position statement of the American Academy of Otolaryngology published in Otolaryngology - Head and Neck Surgery. "Systematic evaluation for reversible causes should precede any expectant management." [16]

Post-COVID Taste Loss: What the Data Show

Post-COVID taste dysfunction deserves its own section because its mechanism differs from classical viral URI-related taste loss. SARS-CoV-2 appears to damage sustentacular (supporting) cells in the olfactory epithelium via ACE2 receptor binding, and the inflammatory cascade spills over into adjacent gustatory structures. Taste receptor cells themselves express ACE2 at lower levels than olfactory epithelium, which may explain why smell loss is more common and more persistent than taste loss after COVID-19.

A large prospective cohort study (N=2,428) published in The Lancet Respiratory Medicine found that at six months post-infection, 11% of patients still reported taste or smell dysfunction. [17] Persistent post-COVID chemosensory disorder at beyond six months is now classified under the post-COVID condition (Long COVID) definition by the WHO. [18]

For patients with persistent post-COVID taste loss, the current evidence supports olfactory and gustatory training as the only intervention with RCT-level backing. Alpha-lipoic acid and vitamin A nasal drops, studied in post-viral smell loss, do not yet have strong gustatory-specific trial data.